Concepedia

Katherine Hanlon

KH

8

Publications

341

Citations

8

H-Index

2010

Active since

Affiliations

University of Arizona(Current)

University of New England

New England College

Katherine Hanlon is an author at University of Arizona specializing in medicine, cell biology, and drug discovery.

Top concepts

MedicineCell BiologyPharmacologyPain MedicinePain ResearchDrug DiscoveryHealthSurgeryCannabisAddiction

Publications per year

2010–2017

8

Publications

8

Disease modification of breast cancer–induced bone remodeling by cannabinoid 2 receptor agonists

Alysia N Lozano‐Ondoua, Katherine Hanlon, Ashley M. Symons-Liguori et al. · Journal of Bone and Mineral Research · 2012 · 78 citations · Full text

Pain Therapy, Breast Oncology, Severe Pain +23

Immunosuppressive Effects of Erythropoietin on Human Alloreactive T Cells

Paolo Cravedi, Joaquín Manrique, Katherine Hanlon et al. · Journal of the American Society of Nephrology · 2014 · 62 citations · Full text

Lymphocyte Development, T-regulatory Cell, Immunology +19

Development of Potent μ and δ Opioid Agonists with High Lipophilicity

Yeon Sun Lee, Vinod Kulkarani, Scott Cowell et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain

Katherine Hanlon, Dave S. Herman, Richard S. Agnes et al. · Brain Research · 2011 · 38 citations

Biochemistry, Pain Medicine, Medicine +10

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent

Todd W. Vanderah, Katherine Hanlon, Alysia N Lozano‐Ondoua et al. · Breast Cancer Targets and Therapy · 2016 · 37 citations · Full text

Rows per page

1–5 of 8